CP and neoplasm: After cellular uptake, CP-DDA NPs precisely released DAS and Pt(II) due to the hydrolysis of ester bonds and redox degradation of GSH in the tumor, thereby displaying potent synergistic antitumor activity and reduced toxicities of free drugs (Figure 7B).